PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
200.87
Positive P/E while Healthcare median is negative at -1.91. Peter Lynch would investigate competitive advantages in a distressed Healthcare.
30.02
P/S exceeding 1.5x Healthcare median of 9.12. Jim Chanos would check for potential multiple compression risks.
1.05
P/B less than half the Healthcare median of 2.19. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-188.87
Negative FCF while Healthcare median P/FCF is -9.15. Seth Klarman would investigate cash flow improvement potential.
-272.05
Negative operating cash flow while Healthcare median P/OCF is -7.16. Seth Klarman would investigate operational improvement potential.
1.05
Fair value ratio less than half the Healthcare median of 2.21. Joel Greenblatt would investigate if this discount is justified.
0.12%
Positive earnings while Healthcare median shows losses. Peter Lynch would examine earnings quality advantage.
-0.53%
Negative FCF while Healthcare median yield is -1.47%. Seth Klarman would investigate cash flow improvement potential.